This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

WIRB-Copernicus Group Announces Release Of IRBNet National Research Network® 2012 Benchmark Report

CAMBRIDGE, Mass., Jan. 22, 2013 /PRNewswire/ -- WIRB-Copernicus Group, the world's largest provider of regulatory and ethical review services for human research, today announced the release of the IRBNet National Research Network Benchmark Report, which provides important metrics regarding the timeliness, accuracy, and quality of review and oversight in the field of human subject research protection.


IRBNet, the leading software application supporting institutional review boards (IRBs) in the U.S., publishes the annual National Research Network Benchmark Report to enable research institutions of all types and sizes to concretely measure their internal ethical review processes, compare their performance to other institutions, and use that data to drive improvements which will benefit research subjects, research programs, and the human subject research community.

"The Benchmark Report offers deep insights into compliance oversight that are not available elsewhere," said Andrew Olmsted, Executive Vice President of IRBNet. "This year's report provides a more complete picture of the major components of the IRB approval process, allowing readers to consider precisely how investigator and study coordinator activities contribute to IRB efficiency metrics."

The 2012 Benchmark Report includes more than 90 detailed performance metrics for biomedical and social / behavioral research institutions, based upon anonymous results from more than 100 individual hospital, university and government agency IRBs, and illuminates the activity and productivity of investigators, as well as the IRB administrative offices and reviewers charged with oversight responsibility.

"To run a high-performing research program, you must first create a holistic and objective picture of your research enterprise," said Nick Slack, Vice President for Consulting Services at WIRB-Copernicus Group. "The IRBNet technology solution not only provides an integrated view across internal and external sites and reviews, but generates metrics that reveal the strengths and weaknesses of the program in its entirety."

WIRB-Copernicus Group supports institutional clients with a comprehensive suite of IRB solutions, including outsourced review services, consulting and technology, to enable them to develop high-performing, competitive research programs that are attractive to industry sponsors and contract research organizations (CROs). WIRB-Copernicus Group clients also include the leading industry sponsors and CROs, who rely on the Group's independent IRB services and robust research site network of over 700 high-performing institutions for prompt, accurate and efficient review.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $94.99 -0.02%
FB $99.54 -0.21%
GOOG $678.11 -0.68%
TSLA $148.25 0.18%
YHOO $26.82 -0.85%


Chart of I:DJI
DOW 16,014.38 -12.67 -0.08%
S&P 500 1,852.21 -1.23 -0.07%
NASDAQ 4,268.7630 -14.99 -0.35%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs